NASDAQ:ANGO
AngioDynamics Stock News
$6.04
-0.380 (-5.92%)
At Close: May 17, 2024
AngioDynamics Q3 EPS $0.01 Beats $(0.03) Estimate, Sales $69.78M Beat $68.55M Estimate
11:12am, Tuesday, 07'th Apr 2020AngioDynamics: Fiscal 3Q Earnings Snapshot
11:09am, Tuesday, 07'th Apr 2020
LATHAM, N.Y. (AP) _ AngioDynamics Inc. (ANGO) on Tuesday reported a fiscal third-quarter loss of $5.7 million, after reporting a profit in the same period a year earlier. The Latham, New York-based co
BRIEF-Angiodynamics Reports Q3 Adj. Earnings Per Share $0.01
11:08am, Tuesday, 07'th Apr 2020
AngioDynamics Inc:
AngioDynamics: Fiscal 3Q Earnings Snapshot
11:08am, Tuesday, 07'th Apr 2020
LATHAM, N.Y. (AP) _ AngioDynamics Inc. (ANGO) on Tuesday reported a fiscal third-quarter loss of $5.7 million, after reporting a profit in the same period a year earlier.
The Latham, New York-based co
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
11:00am, Tuesday, 07'th Apr 2020
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial resul
AngioDynamics, Inc. to Host Earnings Call
10:00am, Tuesday, 07'th Apr 2020
NEW YORK, NY / ACCESSWIRE / April 7, 2020 / AngioDynamics, Inc. (NASDAQ:ANGO) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on April 7, 2020 at 8:00 AM
Earnings Scheduled For April 7, 2020
08:34am, Tuesday, 07'th Apr 2020
Companies Reporting Before The Bell
The Greenbrier Companies, Inc. (NYSE: GBX) is projected to report quarterly earnings at $0.29 per share on revenue of $798.97 million....
Advisor Group Inc. Reduces Position in AngioDynamics, Inc. (NASDAQ:ANGO)
08:18am, Tuesday, 07'th Apr 2020
Advisor Group Inc. cut its position in AngioDynamics, Inc. (NASDAQ:ANGO) by 26.8% during the fourth quarter, HoldingsChannel reports. The firm owned 2,945 shares of the medical instruments supplier’
AngioDynamics Q3 2020 Earnings Preview
09:30pm, Monday, 06'th Apr 2020
AngioDynamics (NASDAQ:ANGO) is scheduled to announce Q3 earnings results on Tuesday, April 7th, before market open.The consensus EPS Estimate is -$0.03 (-115.8% Y/Y) and the consensus Revenue Estimate
AngioDynamics (NASDAQ: ANGO) Q2 2020 Earnings Call Transcript | AlphaStreet
05:51pm, Monday, 06'th Apr 2020
Final earnings conference call transcript of AngioDynamics Inc. - ANGO stock
Insights on the Global Tumor Ablation Industry to 2027 - Drivers, Restraints, Opportunities & Threats - ResearchAndMarkets.com
04:08pm, Monday, 06'th Apr 2020
The "Tumor Ablation - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations
06:03pm, Sunday, 05'th Apr 2020
Biotech stocks went along with the broader market flow in the week ended April 3, with the COVID-19 pandemic dictating sentiment. The week witnessed a host of clinical readouts...
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Connor Clark & Lunn Investment Management Ltd.
11:22am, Saturday, 04'th Apr 2020
Connor Clark & Lunn Investment Management Ltd. raised its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 26.9% during the 4th quarter, according to its most recent filing with the Securities and Exchan
Brinker Capital Inc. Sells 5,846 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)
09:12am, Saturday, 04'th Apr 2020
Brinker Capital Inc. cut its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 23.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Acquired by Cubist Systematic Strategies LLC
11:36am, Friday, 03'rd Apr 2020
Cubist Systematic Strategies LLC increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 484.3% in the 4th quarter, according to the company in its most recent filing with the Securities
